A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Geron Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 41,295 shares of GERN stock, worth $137,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,295
Previous 42,805 3.53%
Holding current value
$137,925
Previous $181,000 3.31%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$4.17 - $4.99 $6,296 - $7,534
-1,510 Reduced 3.53%
41,295 $187,000
Q2 2024

Jul 16, 2024

SELL
$3.1 - $5.09 $347 - $570
-112 Reduced 0.26%
42,805 $181,000
Q1 2024

Apr 15, 2024

BUY
$1.75 - $3.44 $337 - $663
193 Added 0.45%
42,917 $141,000
Q4 2023

Jan 30, 2024

BUY
$1.74 - $2.31 $53,731 - $71,332
30,880 Added 260.72%
42,724 $90,000
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $24,990 - $38,848
11,844 New
11,844 $25,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.